The world’s leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
We thank the House for passing the FY26 LHHS funding bill & urge the Senate to follow suit: brnw.ch/21wZkOT
#SaveResearchStopCancer #ASCOAdvocacy
We thank the House for passing the FY26 LHHS funding bill & urge the Senate to follow suit: brnw.ch/21wZkOT
#SaveResearchStopCancer #ASCOAdvocacy
Learn more: brnw.ch/21wZiM5
Learn more: brnw.ch/21wZiM5
Learn more: brnw.ch/21wZfk4
#SaveResearchStopCancer #ASCOAdvocacy
Learn more: brnw.ch/21wZfk4
#SaveResearchStopCancer #ASCOAdvocacy
Registration is still open, so join us in person or online: tinyurl.com/5ecd4wxe
Registration is still open, so join us in person or online: tinyurl.com/5ecd4wxe
Apply by March 31, 2026: brnw.ch/21wZ9ui
#ASCOGlobalImpact
Apply by March 31, 2026: brnw.ch/21wZ9ui
#ASCOGlobalImpact
#ASCOEdBook
#ASCOEdBook
#ASCODailyNews has more: brnw.ch/21wZ79x
#ASCODailyNews has more: brnw.ch/21wZ79x
Discounts offered. Get details & register today: brnw.ch/21wZ5vL
Discounts offered. Get details & register today: brnw.ch/21wZ5vL
Abstracts due Jan. 27 at 11:59 pm (ET): asco.confex.com/asco/2026/cf...
Abstracts due Jan. 27 at 11:59 pm (ET): asco.confex.com/asco/2026/cf...
Congress must provide sustained funding to support the next gen of research innovators: brnw.ch/21wZ1G3
#SaveResearchStopCancer #ASCOAdvocacy
Congress must provide sustained funding to support the next gen of research innovators: brnw.ch/21wZ1G3
#SaveResearchStopCancer #ASCOAdvocacy
Registration is open, so join us in Singapore, June 25-27: brnw.ch/21wZ1ju
#ASCOBT26
Registration is open, so join us in Singapore, June 25-27: brnw.ch/21wZ1ju
#ASCOBT26
@mpishvaian.bsky.social @drkatepedersen.bsky.social
@mpishvaian.bsky.social @drkatepedersen.bsky.social
asco.org/gi-program
asco.org/gi-program
#crcsm
#crcsm
@skopetz.bsky.social
@skopetz.bsky.social
#crcsm
#crcsm
This session includes a press program abstract on GLP-1 receptor agonists as potential cancer prevention Tx strategy: www.asco.org/about-asco/p...
This session includes a press program abstract on GLP-1 receptor agonists as potential cancer prevention Tx strategy: www.asco.org/about-asco/p...
meetings.asco.org/meetings/202...
meetings.asco.org/meetings/202...
#crcsm #ancsm
#crcsm #ancsm
#ASCOBT26
#ASCOBT26